Summary
The degeneration or dysfunction of cholinergic neurons within the basal forebrain of patients with Alzheimer's disease (AD) may be related to the vulnerability of these cells to endogenous glutamate (Beal, 1995; Greenamyre and Young, 1989). The administration of drugs that attenuate the toxic actions of glutamate in the early stages of the disease might significantly delay its rate of progression. Two approaches to neuroprotection from endogenous glutamatergic function were investigated and found to be effective: blockade of voltage-dependent, NMDA-type glutamate receptor channels and antagonism of an NMDA-receptor related glycineB modulatory site.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albin RL, Greenmmyre JT (1992) Alternative excitotoxic hypotheses. 42: Neurol 38: 733–738
Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative disease. Ann Neurol 38: 357–366
Chen J, Graham S, Graham S, Moroni F, Simon R (1993) A study of the dose dependency of a glycine receptor antagonist in focal ischemia. J Pharmacol Exp Ther 267: 937–941
Fonnum F (1969) Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem J 115: 465–472
Greenmayre JT, Young AB (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol Aging 10: 593–602
Huettner JE, Bean BP (1988) Block of N-methyl-D-aspartate activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci USA 85: 1307–1311
Kemp JA, Foster AC, Leeson PD, Priestley T, Tridgett R, Iversen LL, Woodruff GN (1988) 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci USA 85: 6547–6550
Kleckner N, Dingledine R (1988) Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 241: 835–837
Lanthorn TH (1994) D-Cycloserine: agonist turned antagonist. Amino Acids 6: 247–260
Lester RAJ, Tong G, Jahr CE (1993) Interactions between the glycine and glutamate binding sites of the NMDA receptor. J Neurosci 13: 1088–1096
Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307: 462–465
Rasmusson DD, Clow K, Szerb JC (1994) Modification of neocortical acetylcholine release and EEG desynchronization due to brainstem stimulation by drugs applied to the basal forebrain. Neurosci 60: 665–677
Rothman SM (1992) Excitotoxins: possible mechanisms of action. Ann NY Acad Sci 648: 132–139
Watkins JC, Evans RH (1981) Excitatory amino acid transmitters. Ann Rev Pharmacol Toxicol 21: 165–204
Wenk GL, Danysz W, Mobley SL (1995) MK-801, memantine and amantadine show potent neuroprotective activity against NMDA toxicity in the NBM — a dose response study. Eur J Pharmacol 293: 267–270
Wenk GL, Danysz W, Roice DD (1996) The effects of mitochondrial failure upon cholinergic toxicity in the nucleus basalis. Neuroreport 7: 1453–1456
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wenk, G.L., Baker, L.M., Hauss-Wegrzyniakl, B. et al. Novel glycineB antagonists show neuroprotective activityin vivo . Amino Acids 14, 223–226 (1998). https://doi.org/10.1007/BF01345266
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01345266